Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to $328000.0.

  • Apyx Medical's Change in Account Payables rose 16919.83% to $328000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 79944.75%. This contributed to the annual value of -$63000.0 for FY2024, which is 35200.0% down from last year.
  • Apyx Medical's Change in Account Payables amounted to $328000.0 in Q3 2025, which was up 16919.83% from $513000.0 recorded in Q2 2025.
  • Over the past 5 years, Apyx Medical's Change in Account Payables peaked at $782000.0 during Q1 2021, and registered a low of -$776000.0 during Q1 2023.
  • For the 5-year period, Apyx Medical's Change in Account Payables averaged around $89105.3, with its median value being $254000.0 (2024).
  • Within the past 5 years, the most significant YoY rise in Apyx Medical's Change in Account Payables was 79285.71% (2023), while the steepest drop was 142156.86% (2023).
  • Apyx Medical's Change in Account Payables (Quarter) stood at -$401000.0 in 2021, then skyrocketed by 226.18% to $506000.0 in 2022, then grew by 26.09% to $638000.0 in 2023, then increased by 18.5% to $756000.0 in 2024, then tumbled by 56.61% to $328000.0 in 2025.
  • Its last three reported values are $328000.0 in Q3 2025, $513000.0 for Q2 2025, and -$331000.0 during Q1 2025.